{"id":"W2979878225","doi":"10.1182/blood.v124.21.3624.3624","title":"Development of a Clinically Relevant in Vitro Drug Screening Platform for Chemo-Refractory AML Patients","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacology; Bortezomib; Homoharringtonine; Oncology; Myeloid leukemia; Cytarabine; Proteasome inhibitor; Internal medicine; Panobinostat; Idarubicin; Cancer research; Multiple myeloma; Biology; Histone deacetylase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008452007,0.0009393176,0.001198449,0.0007804448,0.0003272659,0.001043185,0.000637962,0.0007766637,0.002519799],"category_scores_gemma":[0.0007936644,0.0004741281,0.000575405,0.0004457405,0.0002353635,0.0003225988,0.0006023102,0.0009289639,0.001810247],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000532928,"about_ca_system_score_gemma":0.0005832185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006409633,"about_ca_topic_score_gemma":0.001134068,"domain_scores_codex":[0.9990122,0.0003035679,0.0001028773,0.0001893703,0.0003033841,0.00008854816],"domain_scores_gemma":[0.9996004,0.00008739029,0.00006336478,0.00005315351,0.0001310596,0.00006468902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003914328,0.0003353228,0.0009999329,0.0002078555,0.00004014461,0.000104799,0.00003014928,0.003253614,0.9824142,0.0001435794,0.001021047,0.01105791],"study_design_scores_gemma":[0.0001070425,0.001607093,0.002158445,0.00002711796,0.0001127222,0.0003459548,0.00003789083,0.01204346,0.9716764,0.0001588047,0.01168961,0.00003542693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7762086,0.01061344,0.1786531,0.001976232,0.0007869953,0.003461152,0.01390339,0.004590893,0.009806133],"genre_scores_gemma":[0.8469635,0.004768232,0.1229992,0.0009199501,0.0001494659,0.002174017,0.01574772,0.0002138629,0.006064085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002519799,"threshold_uncertainty_score":0.008429527,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02776660771647171,"score_gpt":0.3055776461738024,"score_spread":0.2778110384573307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}